Print this page
-
A Phase 1 Study to Assess the Safety and Efficacy of LYL845 in Adults with Relapsed and/or Refractory Metastatic or Locally Advanced Melanoma and Selected Solid Tumor Malignancies.
Protocol: 092205Principal Investigator:
- Sarah Weiss MD (Rutgers Cancer Institute of New Jersey)
Applicable Disease Sites: Melanoma, Skin -
NCI 10204 - A Phase 1b Study of Nivolumab in Patients with Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)
Protocol: 092305Principal Investigator:
- Sarah Weiss MD (Rutgers Cancer Institute of New Jersey)
Applicable Disease Sites: Melanoma, Skin -
A Digital Intervention to Improve Skin Self-Examination Among Melanoma Survivors.
Protocol: 132202Principal Investigator:
- Sharon Manne PhD (Rutgers University)
Applicable Disease Sites: Melanoma, Skin -
A Multi-Level Investigation of US Indoor Tanning Policy Enactment, Implementation, Compliance, Impact, and Economics.
Protocol: 132005Principal Investigator:
- Carolyn Heckman Ph.D. (Rutgers University)
Applicable Disease Sites: Melanoma, Skin -
Developing and Testing a Mobile Health Intervention to Promote Sun Protection Behaviors and Skin Examination Among Hispanics.
Protocol: 132206Principal Investigator:
- Zhaomeng Niu PhD (Rutgers University)
Applicable Disease Sites: Other Skin -
Facebook Intervention for Young Onset Melanoma Patients and Families.
Protocol: 131812Principal Investigator:
- Sharon Manne PhD (Rutgers University)
Applicable Disease Sites: Melanoma, Skin